NUWE
Nuwellis, Inc.
Nuwellis, Inc. (NUWE) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 20.3 (oversold), with 0/3 trend checks passing.
NUWE with MA50 and MA200
Key levels & signals
Nuwellis, Inc. (NUWE) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $3.12, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 81.5% and below the 200-day moving average by 94.9%.
NUWE currently has an RSI reading of 20.3, which places it in a deeply oversold zone. That can sometimes lead to bounce-watch setups, but it can also reflect genuine weakness, so the chart still needs proper confirmation rather than hope alone.
For traders reviewing NUWE next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.
About Nuwellis, Inc.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
NUWE shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about NUWE
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.